Androgen Deprivation Therapy
Alternative Names: ADT
Androgen Deprivation Therapy (ADT) is a critical component of treatment for locally advanced prostate cancer (T3–T4) and is almost always used in combination with external beam radiation therapy (EBRT). ADT lowers testosterone levels, which prostate cancer cells depend on for growth and survival.
For locally advanced disease, long-term ADT—typically 18 to 36 months—is recommended, based on strong evidence showing improved overall survival and reduced recurrence when used with radiation. Common agents include leuprolide, goserelin, degarelix, and relugolix. While effective, prolonged ADT can cause side effects such as hot flashes, loss of libido, fatigue, bone thinning, and metabolic changes, so patients should be monitored and counseled on managing these risks.
Treatment Type: Prescription Medication
Treatment Class: N/A
Treatment Modality: N/A
Review Summary
Based on the provided information, there are no user reviews available for the effectiveness of 'Androgen Deprivation Therapy' against 'Prostate Cancer, Locally Advanced Disease'. The author of the content has not provided a review or rating for this treatment, making it difficult to assess its efficacy without further data.
This summary was generated by users' reviews
Breakdown by Category
Each categories are rated on a 1–5 scale, with 5 being the most favorable outcome and 1 being the least. These scores are averaged across all user reviews to provide a clear sense of how this treatment typically performs in each area.
Explore various treatment options to empower yourself in making a well-informed choice.
Choose treatments from the menu above to see how they compare side by side.
Choose treatments from the menu above to see how they compare side by side.
Choose treatments from the menu above to see how they compare side by side.
AI Summary of User Experiences
Not medical advice.
Based on the provided information, there are no user reviews available for the effectiveness of 'Androgen Deprivation Therapy' against 'Prostate Cancer, Locally Advanced Disease'. The author of the content has not provided a review or rating for this treatment, making it difficult to assess its efficacy without further data.
Reviews
Filter by reviewer type Pro